[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100629101":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":24,"responsibleParty":42,"collaborators":18,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":48,"sex":54,"minAge":55,"maxAge":18,"enrollmentInfo":56,"targetDuration":18,"studyType":59,"phases":60,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":71,"whyStopped":18,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Universidad Europea de Madrid","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","EXPERIMENTAL","12 weeks of hypertrophy training in patients with advanced, unresectable PC receiving chemotherapy and\u002For immunotherapy",[13],"Other: supervised, hypertrophy-oriented strength training program",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","NO_INTERVENTION","Participants in the control group will receive standard oncological treatment. No restrictions on physical activity will be imposed. Furthermore, they will be offered the opportunity to follow the exercise program used in the intervention group if the expected benefits proposed in the study hypothesis are confirmed.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"supervised, hypertrophy-oriented strength training program","12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass",[9],[25],{"facility":5,"status":18,"city":26,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Madrid","28670","Spain","ES",{"type":31,"coordinates":32},"Point",[33,34],-3.70256,40.4165,{"lat":34,"lon":33},[37],{"name":38,"role":39,"phone":40,"phoneExt":18,"email":41},"Pablo B Arias, Msc","CONTACT","+34 636620771","pablo.braceras@universidadeuropea.es",{"type":43,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"PRINCIPAL_INVESTIGATOR","Lidia Brea Alejo","Director","100629101","impact-of-hypertrophy-oriented-resistance-training-on-muscle-mass-and-quality-of-life-in-patients-with-unresectable-pancreatic-cancer-100629101",false,"NCT07470268","Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer","Impact of Hypertrophy-oriented Resistance Training on Muscle Mass and Quality of Life in Patients With Unresectable Pancreatic Cancer (HY-PANC): Study Protocol for a Randomized Controlled Trial.","HY-PANC","Inclusion Criteria:\n\n* Diagnosis of locally advanced or metastatic unresectable pancreatic cancer\n* Undergoing chemotherapy or immunotherapy treatment\n* Age ≥ 18 years\n* ECOG score ≤ 2\n\nExclusion Criteria:\n\n* Any relative or absolute contraindication that prevents the performance of training or physical tests.\n* Diagnosis of other types of primary cancer\n* Inability to understand Spanish for proper comprehension of the informed consent and questionnaires","ALL","18 Years",{"count":57,"type":58},10,"ESTIMATED","INTERVENTIONAL",[61],"NA","To determine the efficacy of a 12-week supervised, hypertrophy-oriented strength training program in preserving skeletal muscle mass, physical function, and quality of life in patients with unresectable pancreatic cancer compared to standard care.",[64],"Pancreatic Cancer",[66,67,68,69,70],"physical activity","physical function","body composition","lean mass","chemotherapy","NOT_YET_RECRUITING","2026-03-16",{"date":74,"type":75},"2026-03-18","ACTUAL",{"date":77,"type":58},"2026-09-01",{"date":79,"type":58},"2027-09-01",{"name":5,"class":6},1]